MarketCap
Facebook
X
TelegramAnnual report 2024
added 04-25-2026
Nano-X Imaging Ltd. Retained Earnings 2011-2026 | NNOX
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Nano-X Imaging Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -374 M | -320 M | -259 M | -146 M | -84.4 M | -40.6 M | -18 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -18 M | -374 M | -178 M |
Quarterly Retained Earnings Nano-X Imaging Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -146 M | - | - | - | -84.4 M | - | - | - | -40.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -40.6 M | -146 M | -90.4 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.26 | 4.63 % | $ 1.37 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 13.03 | 1.8 % | $ 1.76 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 63.81 | -0.61 % | $ 3.48 B |  Britain |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
LENSAR
LNSR
|
-178 M | $ 5.1 | 0.2 % | $ 61 M | USA |
 |
Pulmonx Corporation
LUNG
|
-522 M | $ 1.27 | 0.39 % | $ 51.7 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Insulet Corporation
PODD
|
287 M | $ 190.15 | 0.31 % | $ 13.4 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.63 | 0.86 % | $ 39.2 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.27 | 1.24 % | $ 122 M |  France |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 11.52 | -2.21 % | $ 326 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 93.82 | -1.11 % | $ 12.7 B | USA |
 |
Sintx Technologies
SINT
|
-292 M | $ 2.5 | 1.21 % | $ 6.93 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 26.45 | -0.11 % | $ 224 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
Stryker Corporation
SYK
|
20.5 B | $ 328.51 | 0.31 % | $ 126 B | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Tactile Systems Technology
TCMD
|
54.9 M | $ 24.95 | -0.48 % | $ 571 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
TransMedics Group
TMDX
|
-278 M | $ 109.0 | -1.74 % | $ 3.71 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 16.3 | 0.65 % | $ 382 M | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 5.38 | 0.94 % | $ 1.14 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Varex Imaging Corporation
VREX
|
-5.9 M | $ 12.49 | -0.32 % | $ 517 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 10.99 | 1.38 % | $ 394 M | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.09 | 2.83 % | $ 18.5 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 39.54 | 3.13 % | $ 1.23 B | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 55.85 | -0.82 % | $ 1.64 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 84.93 | -1.27 % | $ 2.95 B | USA |
 |
PAVmed
PAVM
|
-259 M | $ 8.81 | -2.11 % | $ 5.91 M | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 83.67 | -0.57 % | $ 48.9 B | USA |